Alpha-2-adrenergic receptor agonists for treatment of presbyopia, visual glare, visual starbursts, visual halos and night myopia | Patent Number 11077053

US 11077053 B2
Application Number16950574
Publication NumberUS 20210059930 A1
Pendency8 months, 19 days
Filled DateNov 17, 2020
Priority DateAug 21, 2018
Publication DateMar 4, 2021
Expiration DateAug 20, 2038
Inventor/ApplicantsWayne Chen
Miguel Alcantara
Daniel W. Gil
Mohammed Dibas
ExaminesAZPURU, CARLOS A
Art Unit1617
Technology Center1600
Assignments
Allergan
Current
AllerganAbbvie Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.